Stephens Inc Exelixis, Inc. Transaction History

Stephens Inc

$6.77 Billion
Q3 2024

A detailed history of Stephens Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Stephens Inc holds 9,689 shares of EXEL stock, worth $348,125. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,689

Holding current value

$348,125

% of portfolio

0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$21.96 - $27.6 $212,770 - $267,416	9,689 New	9,689 $251,000
Q1 2024 May 15, 2024	SELL	$20.17 - $23.93 $564 - $670	-28 Reduced 0.32%	8,664 $205,000
Q4 2023 Feb 13, 2024	SELL	$19.25 - $24.13 $7,218 - $9,048	-375 Reduced 4.14%	8,692 $208,000
Q3 2023 Nov 14, 2023	SELL	$19.04 - $22.74 $1,123 - $1,341	-59 Reduced 0.65%	9,067 $198,000
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $4,179 - $4,710	-230 Reduced 2.46%	9,126 $174,000
Q1 2023 May 15, 2023	BUY	$16.3 - $19.41 $5,053 - $6,017	310 Added 3.43%	9,356 $181,000
Q3 2022 Nov 02, 2022	SELL	$15.68 - $22.27 $1,724 - $2,449	-110 Reduced 1.2%	9,046 $142,000
Q2 2022 Aug 03, 2022	SELL	$17.44 - $23.16 $6,941 - $9,217	-398 Reduced 4.17%	9,156 $191,000
Q1 2022 May 04, 2022	SELL	$17.03 - $22.67 $3,371 - $4,488	-198 Reduced 2.03%	9,554 $217,000
Q4 2021 Mar 07, 2022	BUY	$15.84 - $21.88 $31,743 - $43,847	2,004 Added 25.86%	9,752 $178,000
Q3 2021 Oct 27, 2021	BUY	$16.3 - $21.14 $40,570 - $52,617	2,489 Added 47.33%	7,748 $164,000
Q2 2021 Aug 12, 2021	BUY	$17.95 - $25.56 $26,530 - $37,777	1,478 Added 39.09%	5,259 $96,000
Q1 2021 May 14, 2021	BUY	$20.53 - $25.22 $70,787 - $86,958	3,448 Added 1035.44%	3,781 $85,000
Q4 2020 Feb 10, 2021	SELL	$18.39 - $24.8 $6,730 - $9,076	-366 Reduced 52.36%	333 $7,000
Q3 2020 Nov 13, 2020	BUY	$20.67 - $26.94 $2,335 - $3,044	113 Added 19.28%	699 $17,000
Q2 2020 Aug 24, 2020	BUY	$16.46 - $27.42 $6,254 - $10,419	380 Added 184.47%	586 $14,000
Q1 2020 May 14, 2020	SELL	$14.46 - $21.8 $1,344 - $2,027	-93 Reduced 31.1%	206 $4,000
Q3 2019 Oct 18, 2019	BUY	$17.68 - $22.65 $866 - $1,109	49 Added 19.6%	299 $5,000
Q2 2019 Aug 01, 2019	BUY	$18.93 - $24.75 $2,839 - $3,712	150 Added 150.0%	250 $5,000
Q1 2019 May 03, 2019	SELL	$19.6 - $24.76 $4,370 - $5,521	-223 Reduced 69.04%	100 $2,000
Q4 2018 Feb 11, 2019	BUY	$13.65 - $21.8 $996 - $1,591	73 Added 29.2%	323 $6,000
Q3 2018 Nov 14, 2018	BUY	$15.87 - $22.4 $3,967 - $5,600	250 New	250 $4,000

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.2 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.05 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$913 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$552 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$411 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account